SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey

Mohamed Bailor Barrie, Sulaiman Lakoh, J. Daniel Kelly, Joseph Sam Kanu, James Squire, Zikan Koroma, Silleh Bah, Osman Sankoh, Abdulai Brima, Rashid Ansumana, Sarah A. Goldberg, Smit Chitre, Chidinma Osuagwu, Justin Maeda, Bernard Barekye, Tamuno-Wari Numbere, Mohammed Abdulaziz, Anthony Mounts, Curtis Blanton, Tushar Singh, Mohamed Samai, Mohamed A. Vandi, Eugene T. Richardson
doi: https://doi.org/10.1101/2021.06.27.21259271

Data Availability

A subset of the key anonymized individual participant data collected is available upon request to the corresponding author, after approval of a proposal with a signed data access agreement.

Back to top
Posted July 05, 2021.
Download PDF
Data/Code
Email
SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey
Mohamed Bailor Barrie, Sulaiman Lakoh, J. Daniel Kelly, Joseph Sam Kanu, James Squire, Zikan Koroma, Silleh Bah, Osman Sankoh, Abdulai Brima, Rashid Ansumana, Sarah A. Goldberg, Smit Chitre, Chidinma Osuagwu, Justin Maeda, Bernard Barekye, Tamuno-Wari Numbere, Mohammed Abdulaziz, Anthony Mounts, Curtis Blanton, Tushar Singh, Mohamed Samai, Mohamed A. Vandi, Eugene T. Richardson
medRxiv 2021.06.27.21259271; doi: https://doi.org/10.1101/2021.06.27.21259271
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area